The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Adenocarcinoma, Clear Cell

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Adenocarcinoma, Clear Cell


High impact information on Adenocarcinoma, Clear Cell


Chemical compound and disease context of Adenocarcinoma, Clear Cell


Biological context of Adenocarcinoma, Clear Cell


Anatomical context of Adenocarcinoma, Clear Cell


Gene context of Adenocarcinoma, Clear Cell


  1. Detection and clinical correlations of ras gene mutations in human ovarian tumors. Varras, M.N., Sourvinos, G., Diakomanolis, E., Koumantakis, E., Flouris, G.A., Lekka-Katsouli, J., Michalas, S., Spandidos, D.A. Oncology (1999) [Pubmed]
  2. Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison. Gilcrease, M.Z., Delgado, R., Vuitch, F., Albores-Saavedra, J. Hum. Pathol. (1998) [Pubmed]
  3. Overexpression of dihydrodiol dehydrogenase is associated with cisplatin-based chemotherapy resistance in ovarian cancer patients. Chen, Y.J., Yuan, C.C., Chow, K.C., Wang, P.H., Lai, C.R., Yen, M.S., Wang, L.S. Gynecol. Oncol. (2005) [Pubmed]
  4. Overexpression of HER-2/neu is not a risk factor in ovarian clear cell adenocarcinoma. Tanabe, H., Nishii, H., Sakata, A., Suzuki, K., Mori, Y., Shinozaki, H., Watanabe, A., Ochiai, K., Yasuda, M., Tanaka, T. Gynecol. Oncol. (2004) [Pubmed]
  5. Hypercalcemia due to parathyroid hormone-related protein produced by primary ovarian clear cell adenocarcinoma: case report. Tsunematsu, R., Saito, T., Iguchi, H., Fukuda, T., Tsukamoto, N. Gynecol. Oncol. (2000) [Pubmed]
  6. Cancer risk in women exposed to diethylstilbestrol in utero. Hatch, E.E., Palmer, J.R., Titus-Ernstoff, L., Noller, K.L., Kaufman, R.H., Mittendorf, R., Robboy, S.J., Hyer, M., Cowan, C.M., Adam, E., Colton, T., Hartge, P., Hoover, R.N. JAMA (1998) [Pubmed]
  7. Long-term effects of neonatal estrogen treatment on mitogen responsiveness of mouse spleen lymphocytes. Kalland, T., Strand, O., Forsberg, J.G. J. Natl. Cancer Inst. (1979) [Pubmed]
  8. Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets. Hirasawa, A., Saito-Ohara, F., Inoue, J., Aoki, D., Susumu, N., Yokoyama, T., Nozawa, S., Inazawa, J., Imoto, I. Clin. Cancer Res. (2003) [Pubmed]
  9. Beta-catenin mutations in pulmonary blastomas: association with morule formation. Sekine, S., Shibata, T., Matsuno, Y., Maeshima, A., Ishii, G., Sakamoto, M., Hirohashi, S. J. Pathol. (2003) [Pubmed]
  10. Selective inhibition of the epidermal growth factor receptor by ZD1839 decreases the growth and invasion of ovarian clear cell adenocarcinoma cells. Fujimura, M., Hidaka, T., Saito, S. Clin. Cancer Res. (2002) [Pubmed]
  11. Primary non-clear-cell adenocarcinomas of the vagina in older DES-exposed women. DeMars, L.R., Van Le, L., Huang, I., Fowler, W.C. Gynecol. Oncol. (1995) [Pubmed]
  12. Fractal tumor growth of ovarian cancer: sonographic evaluation. Kikuchi, A., Kozuma, S., Sakamaki, K., Saito, M., Marumo, G., Yasugi, T., Taketani, Y. Gynecol. Oncol. (2002) [Pubmed]
  13. Remarkable suppressive effect of consecutive low-dose cisplatin therapy on advanced ovarian clear cell adenocarcinoma. Umesaki, N., Tanaka, T., Kawamura, N., Miyama, M., Ichimura, T., Ogita, S. Oncol. Rep. (1999) [Pubmed]
  14. Cyclophosphamide and 5-fluorouracil act synergistically in ovarian clear cell adenocarcinoma cells. Ohta, I., Gorai, I., Miyamoto, Y., Yang, J., Zheng, J.H., Kawata, N., Hirahara, F., Shirotake, S. Cancer Lett. (2001) [Pubmed]
  15. Superoxide anions and other components of human renal adenocarcinoma. Wickramasinghe, R.H., Reddy, P.R., Klein, L., Villee, C.A. Clin. Biochem. (1976) [Pubmed]
  16. Bcl-2 protein expression associated with resistance to apoptosis in clear cell adenocarcinomas of the vagina and cervix expressing wild-type p53. Waggoner, S.E., Baunoch, D.A., Anderson, S.A., Leigh, F., Zagaja, V.G. Ann. Surg. Oncol. (1998) [Pubmed]
  17. WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma. Kaneuchi, M., Sasaki, M., Tanaka, Y., Shiina, H., Yamada, H., Yamamoto, R., Sakuragi, N., Enokida, H., Verma, M., Dahiya, R. Cancer (2005) [Pubmed]
  18. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero. Boyd, J., Takahashi, H., Waggoner, S.E., Jones, L.A., Hajek, R.A., Wharton, J.T., Liu, F.S., Fujino, T., Barrett, J.C., McLachlan, J.A. Cancer (1996) [Pubmed]
  19. Mitochondria in platinum resistant cells. Isonishi, S., Saitou, M., Yasuda, M., Tanaka, T. Hum. Cell (2001) [Pubmed]
  20. Establishment and characterization of cell line SFCC from clear cell adenocarcinoma of the uterine cervix. Ochiai, A., Takanashi, A., Takekura, N., Nakatani, H., Oda, N., Kameda, T., Tahara, E. Cancer (1989) [Pubmed]
  21. Immunohistochemical distribution of tumor-associated antigen CA6 in gynecological neoplasms as detected by monoclonal antibody DS6. Smith, N.L., Halliday, B.E., Finley, J.L., Wennerberg, A.E. Int. J. Gynecol. Pathol. (2001) [Pubmed]
  22. Conservative surgery plus adjuvant therapy for vulvovaginal rhabdomyosarcoma, diethylstilbestrol clear cell adenocarcinoma of the vagina, and unilateral germ cell tumors of the ovary. Hicks, M.L., Piver, M.S. Obstet. Gynecol. Clin. North Am. (1992) [Pubmed]
  23. PTEN expression in clear cell adenocarcinoma of the ovary. Hashiguchi, Y., Tsuda, H., Inoue, T., Berkowitz, R.S., Mok, S.C. Gynecol. Oncol. (2006) [Pubmed]
  24. Carbohydrate epitopes and mucins expressed by 17 human ovarian carcinoma cell lines. Tamada, Y., Iida, S., Aoki, D., Nozawa, S., Irimura, T. Oncol. Res. (1999) [Pubmed]
  25. Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer. Ikeda, K., Sakai, K., Yamamoto, R., Hareyama, H., Tsumura, N., Watari, H., Shimizu, M., Minakami, H., Sakuragi, N. Int. J. Gynecol. Cancer (2003) [Pubmed]
  26. Cyclin E amplification and overexpression in clear cell adenocarcinoma of the ovary. Tsuda, H., Bandera, C.A., Birrer, M.J., Hashiguchi, Y., Berkowitz, R.S., Mok, S.C. Oncology (2004) [Pubmed]
WikiGenes - Universities